Shanghai Labway Clinical Laboratory (301060) Stock Overview
Shanghai Labway Clinical Laboratory Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
301060 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Shanghai Labway Clinical Laboratory Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥10.23 |
| 52 Week High | CN¥12.66 |
| 52 Week Low | CN¥7.66 |
| Beta | 0.52 |
| 1 Month Change | 12.05% |
| 3 Month Change | -1.82% |
| 1 Year Change | -1.45% |
| 3 Year Change | -61.09% |
| 5 Year Change | n/a |
| Change since IPO | -44.01% |
Recent News & Updates
Recent updates
Optimistic Investors Push Shanghai Labway Clinical Laboratory Co., Ltd (SZSE:301060) Shares Up 32% But Growth Is Lacking
Feb 17
Is Shanghai Labway Clinical Laboratory (SZSE:301060) Using Too Much Debt?
Dec 19What Shanghai Labway Clinical Laboratory Co., Ltd's (SZSE:301060) 50% Share Price Gain Is Not Telling You
Oct 09Calculating The Intrinsic Value Of Shanghai Labway Clinical Laboratory Co., Ltd (SZSE:301060)
Sep 30Investor Optimism Abounds Shanghai Labway Clinical Laboratory Co., Ltd (SZSE:301060) But Growth Is Lacking
Aug 13Market Cool On Shanghai Labway Clinical Laboratory Co., Ltd's (SZSE:301060) Revenues Pushing Shares 36% Lower
Apr 21A Piece Of The Puzzle Missing From Shanghai Labway Clinical Laboratory Co., Ltd's (SZSE:301060) 28% Share Price Climb
Mar 07Shareholder Returns
| 301060 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | 1.1% | -0.07% | -1.6% |
| 1Y | -1.4% | -3.3% | 19.9% |
Return vs Industry: 301060 matched the CN Healthcare industry which returned -1.8% over the past year.
Return vs Market: 301060 underperformed the CN Market which returned 23% over the past year.
Price Volatility
| 301060 volatility | |
|---|---|
| 301060 Average Weekly Movement | 3.2% |
| Healthcare Industry Average Movement | 3.6% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in CN Market | 9.3% |
| 10% least volatile stocks in CN Market | 3.0% |
Stable Share Price: 301060 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 301060's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 1,365 | Wai-Hung Tsang | www.labway.cn |
Shanghai Labway Clinical Laboratory Co., Ltd. engages in the sale of vitro diagnostic products. It sells vitro diagnostic instruments, reagents, and related accessories and consumables.
Shanghai Labway Clinical Laboratory Co., Ltd Fundamentals Summary
| 301060 fundamental statistics | |
|---|---|
| Market cap | CN¥4.08b |
| Earnings (TTM) | -CN¥69.52m |
| Revenue (TTM) | CN¥1.52b |
Is 301060 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301060 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.52b |
| Cost of Revenue | CN¥1.20b |
| Gross Profit | CN¥321.94m |
| Other Expenses | CN¥391.46m |
| Earnings | -CN¥69.52m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.17 |
| Gross Margin | 21.12% |
| Net Profit Margin | -4.56% |
| Debt/Equity Ratio | 11.7% |
How did 301060 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/18 04:03 |
| End of Day Share Price | 2025/11/18 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shanghai Labway Clinical Laboratory Co., Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.